Published in J Neuropathol Exp Neurol on July 01, 2015
Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J Cereb Blood Flow Metab (2016) 0.88
Hippocampal Sclerosis but Not Normal Aging or Alzheimer Disease Is Associated With TDP-43 Pathology in the Basal Forebrain of Aged Persons. J Neuropathol Exp Neurol (2016) 0.78
Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology. Neurobiol Aging (2016) 0.77
Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging. Acta Neuropathol (2016) 0.76
Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe. J Alzheimers Dis (2016) 0.76
Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2. Neurobiol Aging (2017) 0.75
Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi. Brain Pathol (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun (2006) 10.69
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology (2006) 8.97
Neuropathologic substrate of mild cognitive impairment. Arch Neurol (2006) 6.26
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol (2007) 5.98
TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol (2010) 4.48
Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol (2007) 4.47
Initiation and synergistic fibrillization of tau and alpha-synuclein. Science (2003) 3.76
Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain (2012) 3.43
Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci (2002) 3.11
The TMEM106B locus and TDP-43 pathology in older persons without FTLD. Neurology (2015) 2.81
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65
Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol (2006) 2.57
Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord (2002) 2.56
The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis (2009) 2.54
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44
Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology (2004) 2.42
Clinicopathologic differences among patients with behavioral variant frontotemporal dementia. Neurology (2013) 2.26
Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol (1994) 2.23
Hippocampal sclerosis in advanced age: clinical and pathological features. Brain (2011) 2.16
Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev (2010) 2.06
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol (1998) 1.93
Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease. Neurology (2004) 1.74
Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol (2007) 1.68
Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. Arch Neurol (2002) 1.65
University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res (2012) 1.52
Understanding hippocampal sclerosis in the elderly: epidemiology, characterization, and diagnostic issues. Curr Neurol Neurosci Rep (2008) 1.47
TDP-43 is a key player in the clinical features associated with Alzheimer's disease. Acta Neuropathol (2014) 1.47
Human cerebral neuropathology of Type 2 diabetes mellitus. Biochim Biophys Acta (2008) 1.46
Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol (2013) 1.41
TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol (2013) 1.37
Staging TDP-43 pathology in Alzheimer's disease. Acta Neuropathol (2013) 1.36
Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis Assoc Disord (2011) 1.35
TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol (2011) 1.32
Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener Dis (2010) 1.31
Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old. Brain (2011) 1.29
Potassium channel openers as potential therapeutic weapons in ion channel disease. Kidney Int (2000) 1.25
Estimating the number of persons with frontotemporal lobar degeneration in the US population. J Mol Neurosci (2011) 1.25
KATP channels and cardiovascular disease: suddenly a syndrome. Circ Res (2013) 1.23
Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample. Brain Behav (2012) 1.20
TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia. J Neurochem (2013) 1.18
Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet (2014) 1.17
TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study. J Neuropathol Exp Neurol (2008) 1.16
Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration. Acta Neuropathol (2006) 1.16
Differential clinicopathologic and genetic features of late-onset amnestic dementias. Acta Neuropathol (2014) 1.13
Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain (2013) 1.13
ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol (2014) 1.07
Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol (2015) 1.03
TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system. Acta Neuropathol (2007) 1.02
Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration. J Alzheimers Dis (2014) 1.00
Neuropathology of hippocampal sclerosis. Handb Clin Neurol (2008) 1.00
Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation. Acta Neuropathol (2000) 1.00
Hippocampal sclerosis: progress since Sommer. Brain Pathol (2008) 0.98
Hippocampal sclerosis in Alzheimer disease and other dementias. Neurology (2006) 0.98
Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery. Alzheimers Dement (2014) 0.97
Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome. Arch Neurol (2009) 0.96
CERAD practice effects and attrition bias in a dementia prevention trial. Int Psychogeriatr (2013) 0.95
Consensus recommendations on pathologic changes in the hippocampus: a postmortem multicenter inter-rater study. J Neuropathol Exp Neurol (2013) 0.93
Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial. Trials (2012) 0.90
TDP-43 pathology in the population: prevalence and associations with dementia and age. J Alzheimers Dis (2014) 0.90
Lack of association of the apoE4 allele with hippocampal sclerosis dementia. Neurosci Lett (1996) 0.90
Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions. J Diabetes Complications (2003) 0.89
A population study of Alzheimer's disease: findings from the Cache County Study on Memory, Health, and Aging. Care Manag J (2005) 0.87
Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A. Acta Neuropathol (2014) 0.85
Astrocytic TDP-43 pathology in Alexander disease. J Neurosci (2014) 0.85
Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields. J Neuropathol Exp Neurol (2014) 0.84
Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology. J Neuropathol Exp Neurol (2015) 0.83
TDP-43 pathology is present in most post-encephalitic parkinsonism brains. Neuropathol Appl Neurobiol (2014) 0.78
MRI shows more severe hippocampal atrophy and shape deformation in hippocampal sclerosis than in Alzheimer's disease. Int J Alzheimers Dis (2011) 0.78
Hippocampal sclerosis dementia: An amnesic variant of frontotemporal degeneration. Dement Neuropsychol (2013) 0.76
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet (2005) 10.11
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
A combined computational-experimental approach predicts human microRNA targets. Genes Dev (2004) 9.82
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Neuropathologic substrate of mild cognitive impairment. Arch Neurol (2006) 6.26
Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol (2006) 6.20
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36
The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci (2008) 4.28
An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell (2007) 4.03
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol (2014) 3.75
Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res (2003) 3.71
Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death. Cancer Cell (2007) 3.37
Tooth loss, dementia and neuropathology in the Nun study. J Am Dent Assoc (2007) 3.29
Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest (2005) 3.15
Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. Cancer Res (2005) 2.98
TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol (2007) 2.97
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging (2005) 2.97
Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res (2004) 2.73
Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol (2007) 2.70
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65
Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg (2005) 2.53
Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab (2007) 2.52
Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc (2006) 2.48
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44
Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol (2006) 2.43
Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration. Proc Natl Acad Sci U S A (2008) 2.32
Predicting risk of malignancy in adnexal masses. Obstet Gynecol (2010) 2.31
Age and gender effects on human brain anatomy: a voxel-based morphometric study in healthy elderly. Neurobiol Aging (2006) 2.23
The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol (2010) 2.20
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology (2012) 2.19
Hippocampal sclerosis in advanced age: clinical and pathological features. Brain (2011) 2.16
Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol (2006) 2.13
Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther (2010) 2.09
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells. Cancer Biol Ther (2009) 1.97
Patterns of colorectal cancer incidence, risk factors, and screening in Kentucky. South Med J (2004) 1.94
Dissociation of automatic and strategic lexical-semantics: functional magnetic resonance imaging evidence for differing roles of multiple frontotemporal regions. J Neurosci (2006) 1.92
Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther (2006) 1.88
Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol (2008) 1.88
Selecting treatment for patients with malignant epidural spinal cord compression-does age matter?: results from a randomized clinical trial. Spine (Phila Pa 1976) (2009) 1.79
Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography. Obstet Gynecol (2013) 1.77
Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation. Gynecol Oncol (2003) 1.75
Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol (2009) 1.73
Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts. Cancer Biol Ther (2011) 1.72
Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol (2011) 1.72
Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase. Dig Dis Sci (2007) 1.72
Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol (2010) 1.71
A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. J Neuroinflammation (2007) 1.70
Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. J Neuropathol Exp Neurol (2009) 1.66
Lifelong bilingualism maintains neural efficiency for cognitive control in aging. J Neurosci (2013) 1.62
Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol (2011) 1.62
Protein kinase involved in lung injury susceptibility: evidence from enzyme isoform genetic knockout and in vivo inhibitor treatment. Proc Natl Acad Sci U S A (2003) 1.62
Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer (2007) 1.61
Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res (2004) 1.59
The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy. Cancer (2009) 1.59
Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation. Cancer Res (2007) 1.58
Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A (2008) 1.57